These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32056353)

  • 1. Evaluation of a serum tumour marker-based recurrence prediction model after radiofrequency ablation for hepatocellular carcinoma.
    Yoo J; Lee MW; Lee DH; Lee JH; Han JK
    Liver Int; 2020 May; 40(5):1189-1200. PubMed ID: 32056353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
    Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
    Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis.
    Suwa K; Seki T; Aoi K; Yamashina M; Murata M; Yamashiki N; Nishio A; Shimatani M; Naganuma M
    Abdom Radiol (NY); 2021 Aug; 46(8):3790-3797. PubMed ID: 33675382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival.
    Yang Y; Chen Y; Ye F; Cao X; Xin Y; Wang Y; Lei Y; Li X; Feng D; Zhou X; Fan Q
    Eur Radiol; 2021 May; 31(5):3053-3064. PubMed ID: 33175203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
    Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
    Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early recurrence after radiofrequency ablation for hepatocellular carcinoma: a multicenter retrospective study on definition, patterns and risk factors.
    Yang Y; Xin Y; Ye F; Liu N; Zhang X; Wang Y; Li X; Fan Q; Zhou X; Chen Y
    Int J Hyperthermia; 2021; 38(1):437-446. PubMed ID: 33724137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of no-touch radiofrequency ablation in the treatment of single small hepatocellular carcinoma: A single center long-term follow-up study.
    Wu G; Li J; Li C; Ou X; Feng K; Xia F; Chen Z; Zhang L; Ma K
    Cancer Med; 2023 Mar; 12(6):6571-6582. PubMed ID: 36444873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
    Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
    Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and outcomes of percutaneous radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation: a single-center experience.
    Liu B; Huang G; Xie X; Zhao Q; Su L; Liu M; Li X; Long J; Kuang M; Xie X
    Int J Hyperthermia; 2020; 37(1):1202-1209. PubMed ID: 33100042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma.
    Yoon JH; Goo YJ; Lim CJ; Choi SK; Cho SB; Shin SS; Jun CH
    World J Gastroenterol; 2020 Aug; 26(32):4833-4845. PubMed ID: 32921960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatic distant recurrence following complete radiofrequency ablation of small hepatocellular carcinoma: risk factors and early MRI evaluation.
    Sheng RF; Zeng MS; Ren ZG; Ye SL; Zhang L; Chen CZ
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):603-12. PubMed ID: 26663008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and patterns of recurrence after radiofrequency ablation for hepatocellular carcinoma within up-to-seven criteria: A multicenter retrospective study.
    Yang Y; Chen Y; Zhang X; Xin Y; Wang Y; Li X; Fan Q; Zhou X; Ye F
    Eur J Radiol; 2021 May; 138():109623. PubMed ID: 33711573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
    Liang X; Bu J; Jiang Y; Zhu S; Ye Q; Deng Y; Lu W; Liu Q
    Int J Hyperthermia; 2024; 41(1):2355279. PubMed ID: 38767372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation.
    Lee DH; Lee JM; Yoon JH; Kim YJ; Han JK
    Radiology; 2017 Mar; 282(3):880-891. PubMed ID: 27643670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
    Ziol M; Sutton A; Calderaro J; Barget N; Aout M; Leroy V; Blanc JF; Sturm N; Bioulac-Sage P; Nahon P; Nault JC; Charnaux N; N'kontchou G; Trinchet JC; Delehedde M; Seror O; Beaugrand M; Vicaut E; Ganne-Carrié N
    J Hepatol; 2013 Dec; 59(6):1264-70. PubMed ID: 23928407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rim-arterial enhancing primary hepatic tumors with other targetoid appearance show early recurrence after radiofrequency ablation.
    Cha DI; Lee MW; Jeong WK; Ahn SH; Kang TW; Song KD; Min JH; Rhim H; Lim HK
    Eur Radiol; 2021 Sep; 31(9):6555-6567. PubMed ID: 33713169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study.
    Han X; Dong J; Liu Z; Wu B; Tian Y; Tan H; Cheng W
    Int J Hyperthermia; 2020; 37(1):1066-1073. PubMed ID: 32924654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.
    Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI
    J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.